Raipur/Narayanpur: In a decisive strike against armed Left Wing Extremism in Chhattisgarh's Abujhmad region, Narayanpur ...

Kodiak Solutions completed its acquisition of Besler & Company, LLC (BESLER), a market leader in revenue recovery and hospital reimbursement solutions, on January 22, 2026. Terms of the deal are not ...

Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotypeBLA resubmitted to U.S. FDA in January 2026; ...

Detailed price information for Ultragenyx Pharmaceu (RARE-Q) from The Globe and Mail including charting and trades.

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...

Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotype BLA resubmitted to U.S. FDA in January 2026; Company expects up to six-month review period per FDA guidel ...

Forbes contributors publish independent expert analyses and insights. Building the human future of manufacturing. I’ve never believed that the loudest vision of technology is the most meaningful one.

Introducing the highest U.S. tariffs since the Great Depression, President Donald Trump made a clear promise in the spring: “Jobs and factories will come roaring back into our country.” They haven’t.

China’s manufacturing dominance remains unmatched in Asia, endorsed by scale, innovation, and integrated supply chains. Despite rising costs and geopolitical challenges, China continues to attract ...

Employees and automated robots make solar panels at T1 Energy’s G1_Dallas manufacturing facility on Nov. 13, 2025, in Wilmer. Angela Piazza Inside T1 Energy’s state-of-the-art G1_Dallas facility in ...

If 2025 had a defining theme for manufacturers, it was uncertainty. Not the abstract kind. The operational kind. Tariffs appeared. Disappeared. Reappeared. Pricing decisions got harder. Capital ...

The Global Preeclampsia Diagnostics Market is driven by increased maternal risk factors and advancements in biomarker-based assays, emphasizing early detection. Key opportunities include enhancing ...